• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Teva Teriflunomide
    / Taro International Ltd


    Active Ingredient

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Film Coated Tablets

    28 X 14 mg

    partial basket chart

    Related information


    Dosage

    The recommended dose is 14 mg once daily.


    Indications

    For the treatment of adult patients with relapsing remitting forms of Multiple Sclerosis (MS) to reduce the frequency of clinical relapses and to delay the progression of physical disability.


    Contra-Indications

    * Hypersensitivity to the active substance or to any of the excipients.
    *Severe hepatic impairment (Child-Pugh class C).
    * Pregnant women, or women of childbearing potential, or
    during breast-feeding.
    * Severe immunodeficiency states, e.g. acquired immunodeficiency syndrome (AIDS).
    * Significantly impaired bone marrow function or significant anaemia, leukopenia, neutropenia or thrombocytopenia.
    * Severe active infection until resolution.
    * Severe renal impairment undergoing dialysis.
    * Severe hypoproteinaemia, e.g. in nephrotic syndrome.


    Special Precautions

    Please refer to the license holder for further details.


    Side Effects

    Please refer to the license holder for further details.


    Drug interactions

    Please refer to the license holder for further details.


    Pregnancy and Lactation

    Please refer to the license holder for further details.


    Overdose

    Please refer to the license holder for further details.


    Important notes

    Please refer to the license holder for further details.


    Manufacturer
    Alfred E. Tiefenbacher GMBH&CO. KG (AET)

    סרגל נגישות

    CLOSE